TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Accuracy of ultrasound imaging tool for prostate cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Velocity Time Integral (VTI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Test of neglect severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test of neglect impact on daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients without pressure ulcers
Endpoint domain: Adverse events/effects
Primary endpoint: Success of the manufacture process of the orthosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate to treatment with CAR-T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the concentration-time curve of BI 907828 in plasma over the time interval from 0 to 24 hours (AUC 0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentrations of BI 907828 in plasma (C max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of pain assessed by VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal hypotension during cesarean delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-Reported Stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Reported Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical EVD placement quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of providing virtual reality stimulation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of providing virtual reality stimulation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Treatment-emergent Adverse Events that Led to Study Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to the Dietary Intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction with the Dietary Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cooking Class Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Generalized Anxiety Disorder 7-Item (GAD-7) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in clone size distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimum positive end-expiratory pressure level by compliance win
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Optimum positive end-expiratory pressure level by heart-lung index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dopamine potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in objectively measured sedentary behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histopathological features in liver biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of surgery canceled due to high blood pressure
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Fibroscan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Changes in M2BPGi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Changes in Kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in albumin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in SGOT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Dermatological safety
Endpoint domain: Adverse events/effects
Primary endpoint: Level of kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ankle dorsiflexion range with the knee in extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biochemical recurrence free survival (bPFS)
Endpoint domain: Mortality/survival
Primary endpoint: primary safety endpoint
Endpoint domain: Adverse events/effects
Primary endpoint: primary performance endpoint
Endpoint domain: Physiological/clinical
Primary endpoint: Evaluation of lower limb muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postoperative hemoglobin value (Hb_nadir)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: level of acute pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution or improvement of episodes of urinary loss assessed by pad test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Resolution or improvement of episodes of urinary loss assessed by urinary diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Resolution or improvement of episodes of urinary loss assessed by questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Problematic Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Negativisation rate of positive SARS-CoV-2 PCR test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Area under the concentration-time curve of BI 1584862 in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of BI 1584862 in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fecundity knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in Iron Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Toxic exposure levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: low density lipoprotein (LDL) cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: high density lipoprotein (HDL) cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BM MRD <10-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects experiencing Dose Limiting Toxicities with ALLO-605
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients experiencing Dose Limiting Toxicities with ALLO-647
Endpoint domain: Adverse events/effects
Primary endpoint: Overall response rate (ORR) of ALLO-605
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline values of renal profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage change from baseline scores of serum levels of gut-derived protein bound uremic toxins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change from baseline values of complete blood picture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Late gadolinium enhancement (LGE) positive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extra-cellular volume (ECV) > 30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive Timed Up and Go Test (CTUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-Meter Gait Speed (4MGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dehydration speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic response to initial treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary microvascular dysfunction (CMVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wound dehiscence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of participants who did not continue to use the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Multiple Sclerosis Quality of Life Scale-54
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Electrical properties of breast tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative 7-day cognitive dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety related biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Poor occlusal force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Poor masticatory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Impact Questionnaire-7 (PFIQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prolapse Quality of life questionnaire (P-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Individuals with Overactive Platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of treatment-related and treatment-emergent adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: number of patients and wounds that have an infection or any related adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: number of patients and wounds that result in hospitalization (serious adverse event)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of squamous cell carcinoma
Endpoint domain: Adverse events/effects
Primary endpoint: Delayed language development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Severe Post-prematurity Respiratory Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Infiltration of CD8+ T cells in the CNS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hydration of the cutaneous and genital mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Acceptability of the cutaneous and genital mucosa
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time for establishing a diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respectability of the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Effectiveness of IUD Self-Removal Techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: The Clinical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: triglyceride glucose (TyG) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: residual SYNTAX score (RSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of the PrEPsmart mobile app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the PrEPsmart mobile app
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hemodialysis Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interdialytic Weight (IDW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Therapeutic Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow in pancreatic remnant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: T1 and T2 value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Anti-SARS-CoV-2 IgG Antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Neutralizing Antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Target Area non vellus Hair Counts (TAHC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic objective response rate (hORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of psychosocial linkage
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Severity of chronic pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly time calculation of moderate physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly time calculation of high-intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly time calculation of sedentary activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women who meet AUC target in second trimester
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women who meet AUC target in third trimester
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women who meet AUC target in postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cervical sagittal vertical alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T1 slope angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Albumin-bound Paclitaxel/Granulocyte
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of infective endocarditis
Endpoint domain: Adverse events/effects
Primary endpoint: Distance Visual Acuity with Study Lenses at Year 1 Follow-Up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Microbial Keratitis
Endpoint domain: Adverse events/effects
Primary endpoint: Low Energy Availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference rate for vaginal estradiol cream versus tablet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sensitivity and specificity of lung cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and grade of solicited local and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Differences in reaction to risk communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Differences in behaviour intention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sensitivity and specificity of the Proclarix risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum and Urine CXCL3 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sonographic quality/quantity of the gastric antrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Neuronal structural results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electrophysiological readout (voltage amplitude)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Self-efficacy in ability to continue essential life activities score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Recommended phase 2 dosage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Baseline in CSF Free and Bound MTBR-tau at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Worst Itch Numeric Rating Scale (WI-NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cutometer Skin Elasticity Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cigarette changes from baseline to week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2-response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of sodium fragments in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in severity of acne scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in neuropathic pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in neuropathic pain interference
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes associated with sensory function/dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with preterm preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Relative difference in bone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Duration of corneal ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implantation success rate of LBBaP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of serious adverse events for devices associated with Solia S and Selectra 3D
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of serious adverse events rate
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of total non-calcified coronary plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentration of Glycosylated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of estimated Glomerular Filtration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Concentration of Serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Scan re-scan reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of 30 day-anastomotic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Consumption of norepinephrine and fluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain after cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline to end point in severity subset of the MLGSSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical response rate (PSA50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of patients reaching target Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite Appetite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake (EI) (kilocalories)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in preferred walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall and method-specific PrEP method uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Delivery acceptability among providers
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in dietary intake pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of Plasma Inorganic Pyrophosphate (PPi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Determination of Arterial Calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Determination of range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of performance on the Grapholearn-based decoding task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Clinical Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until first rescue analgesic requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoffending rate
Endpoint domain: Mortality/survival
Primary endpoint: Prediction of steroid dependent hepatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Usefulness of the adherence package AMoPac
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total clinician-reported medical errors
Endpoint domain: Adverse events/effects
Primary endpoint: Early Initiation of Breastfeeding (EIBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes